• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭对利尿剂替唑米胺药代动力学的影响。

Effects of cardiac failure on the pharmacokinetics of the diuretic tizolemide.

作者信息

Beermann B, Edelstam C

出版信息

Eur Heart J. 1984 Apr;5(4):338-42. doi: 10.1093/oxfordjournals.eurheartj.a061661.

DOI:10.1093/oxfordjournals.eurheartj.a061661
PMID:6734643
Abstract

Tizolemide, an alkaline sulphonamide diuretic, was given i.v. in one dose and orally during one week to eight patients with compensated cardiac failure. They had essentially normal glomerular filtration rate but reduced renal plasma flow. Tizolemide was almost completely absorbed from the gastrointestinal tract. The drug was mainly eliminated via tubular secretion. Renal clearance of the drug was much lower than in healthy subjects because of low renal plasma flow. As a consequence plasma half-life was prolonged considerably in some patients. It was concluded that drugs with mainly tubular renal elimination may have a reduced elimination rate in patients with cardiac diseases despite normal glomerular filtration rate.

摘要

替唑米胺是一种碱性磺酰胺类利尿剂,对8例代偿性心力衰竭患者静脉注射单剂量,并在一周内口服给药。这些患者的肾小球滤过率基本正常,但肾血浆流量降低。替唑米胺几乎完全从胃肠道吸收。该药物主要通过肾小管分泌消除。由于肾血浆流量低,该药物的肾清除率远低于健康受试者。因此,部分患者的血浆半衰期显著延长。得出的结论是,主要经肾脏肾小管消除的药物,在患有心脏病的患者中,尽管肾小球滤过率正常,但其消除率可能会降低。

相似文献

1
Effects of cardiac failure on the pharmacokinetics of the diuretic tizolemide.心力衰竭对利尿剂替唑米胺药代动力学的影响。
Eur Heart J. 1984 Apr;5(4):338-42. doi: 10.1093/oxfordjournals.eurheartj.a061661.
2
Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function.替唑米胺在肾功能正常和减退受试者中的利尿作用及药代动力学
Clin Nephrol. 1983 Mar;19(3):124-31.
3
Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.新型袢利尿剂托拉塞米在肾功能不全患者体内的消除动力学研究。
Eur J Clin Pharmacol. 1986;31 Suppl:49-51. doi: 10.1007/BF00541467.
4
The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.慢性肾功能不全患者静脉注射和口服托拉塞米的药代动力学
Clin Pharmacol Ther. 1994 Jul;56(1):31-8. doi: 10.1038/clpt.1994.98.
5
Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.托拉塞米在人体中的药代动力学研究:其利尿作用概述
Int J Clin Pharmacol Ther Toxicol. 1982 Aug;20(8):382-7.
6
Pharmacokinetics of high doses of piretanide in moderate to severe renal failure.高剂量吡咯他尼在中重度肾衰竭患者中的药代动力学
Eur J Clin Pharmacol. 1984;27(5):589-93. doi: 10.1007/BF00556897.
7
Pharmacokinetics of the loop diuretic piretanide in renal failure.
Eur J Clin Pharmacol. 1985;29(3):337-43. doi: 10.1007/BF00544091.
8
The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.吡咯他尼在慢性肾功能不全患者中的药代动力学及利尿作用
Br J Clin Pharmacol. 1983 Mar;15(3):347-53. doi: 10.1111/j.1365-2125.1983.tb01509.x.
9
Kinetics of a high dose of piretanide in renal failure.高剂量布美他尼在肾衰竭中的药代动力学
Eur J Clin Pharmacol. 1982;21(4):307-10. doi: 10.1007/BF00637618.
10
The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease.利尿剂布美他尼在肝脏和肾脏疾病中的药代动力学和药效学
Br J Clin Pharmacol. 1983 Feb;15(2):245-52. doi: 10.1111/j.1365-2125.1983.tb01493.x.